The U.S. House of Representatives passed a sweeping anti-opioid abuse bill Friday with broad bipartisan support, rolling together dozens of other pieces of legislation passed over the last two weeks.
An Illinois federal judge on Thursday ruled that CorVel Corp. can’t force its insurer to cover a nearly $1.4 million arbitration award it was ordered to pay to Hartford Fire Insurance Co. in a dispute over alleged flaws in CorVel’s medical bill review system, finding that a policy exclusion for claims arising from software problems bars coverage.
A once-obscure Texas federal judge who rocketed to prominence after being handpicked to hear lawsuits against the Obama administration is now overseeing his biggest case yet: an existential challenge to the Affordable Care Act. In an interview with Law360, U.S. District Judge Reed O'Connor explained how he's approaching the momentous legal battle.
A district manager with California's Division of Occupational Safety & Health has been charged in state court with accepting bribes in exchange for lowering workspace safety violation penalties faced by a construction company, according to the California attorney general's office.
Cancer-focused biotechnology firm Autolus Therapeutics PLC and medical technology company Electrocore LLC made strong debuts in public markets on Friday after raising $228 million through initial public offerings, concluding a 10-IPO week dominated by the biotechnology sector.
Dockworkers and a medical facility in California hit the providers of a health and welfare plan on Thursday with a suit claiming it owes nearly $6.5 million in unpaid claims that were preapproved, telling a federal judge the plan has violated the Employee Retirement Income Security Act in failing to pay the claims.
In this week’s Taxation with Representation, Veritas-backed Verscend Technologies bought Cotiviti Holdings for $4.9 billion, Roche took over Foundation Medicine in a $2.4 billion deal, Baytex bought Raging River Exploration for $2.1 billion, and William Scotsman took over Modspace in a $1.1 billion deal.
Extra attorneys’ fees can’t be used to address the U.S. Department of Health and Human Services' “egregious” misconduct during a support contract procurement, the Federal Circuit ruled Friday.
Morguard Management has reportedly bought 125 Florida condos for $19 million, real estate investment trust Starwood Property is said to have loaned $213 million for a Los Angeles project that includes hotel and retail components, and Aetna has reportedly leased 85,000 square feet in Florida.
A Florida appeals court on Friday affirmed the license revocation of a plastic surgeon who punctured two patients' organs while performing liposuction, finding that it was acceptable for an administrative law judge and the state medical board to partially base their decisions on his refusal to testify.
Native American law practitioners will be closely tracking a U.S. Supreme Court case that could shake the foundations of tribal, federal and state jurisdiction in Oklahoma, as well as watching a Federal Circuit decision on a New York tribe’s ability to assert sovereign immunity to block a challenge to several patents' validity and keeping an eye on tribes' role in multidistrict opioid litigation in the second half of 2018.
Whistleblowers in a lawsuit accusing grocery store conglomerate SuperValu Inc. of overcharging the federal government for medication asked an Illinois federal judge to sanction the chain, saying it destroyed material evidence that would have helped prove their claims.
A private equity firm led by an ex-Warburg Pincus executive is seeking $1.5 billion for a fund that will invest in Chinese health care and consumer companies, the European Commission will approve the $2.4 billion Tronox-Cristal deal with conditions, and BlackRock wants to buy into an Italian asset manager.
President Donald Trump’s choice to head the Administration for Native Americans at the U.S. Department of Health and Human Services has been cleared by the full U.S. Senate, the chair of the U.S. Senate Committee on Indian Affairs has announced.
Xerox Corp. can’t try to share the blame for what Texas claims is a $1 billion civil Medicaid fraud with orthodontists who allegedly provided unnecessary services to poor children, and the orthodontists can’t pursue claims against the state, the Texas Supreme Court held in a pair of opinions Friday.
A divided Ninth Circuit ruled Wednesday that film producer Nu Image Inc. can't sue in federal court over a union contract provision requiring it to pay into health and pension funds, in a decision that pitted a U.S. Supreme Court ruling against the appeals court’s own precedent.
NYU Hospitals Center has made no showing of an illegal conspiracy between rival hospitals, a union and a former collective labor contracts negotiator, a New York federal judge ruled Wednesday, dismissing the hospital’s antitrust claim while allowing it to pursue allegations that it overpaid into an employee benefit fund.
Assisted living company HCR ManorCare Inc. returned to Delaware bankruptcy court Thursday to receive approval for an updated Chapter 11 plan that will increase recoveries for equity holders if the acquirer of the debtor’s assets closes a merger of its own.
Asked on Thursday to explain the gist of a $10 million clawback suit against Lynn Tilton and her private equity firm, Patriarch Partners LLC, counsel for the liquidating trustee of TransCare Corp. said the distressed-debt maven breached a legal duty to protect the ambulance operator from ruin.
Two trade associations for pharmaceutical benefits managers and health insurers have thrown their support behind Anthem Inc. and Express Scripts Inc. in a dispute at the Second Circuit over the companies’ drug pricing, arguing that the companies weren’t acting as fiduciaries when they contracted together.
Eighty years ago, President Franklin D. Roosevelt signed the Federal Food, Drug, and Cosmetic Act. In recognition of this anniversary, attorneys at Epstein Becker Green review how the act came to be, how it has evolved, and how the U.S. Food and Drug Administration is enforcing its authority under the act to address the demands of rapidly evolving technology.
The U.S. Food and Drug Administration recently provided drug and device manufacturers additional flexibility to convey certain types of truthful, nonmisleading product information. These guidance documents address FDA regulation of manufacturer communications, but the FDA still has work to do to complete its comprehensive review of policies in this area, say attorneys at Ropes & Gray LLP.
Legal industry compensation practices are once again in the news as BigLaw firms continue to match the new high watermark of $190,000 for first-year associate salaries. The typical model of increasing associate salaries uniformly fails star associates, the firms they work for and, ultimately, the clients they serve, says William Brewer, managing partner of Brewer Attorneys & Counselors.
This year, the U.S. Attorney's Office for the District of Massachusetts has investigated several life sciences companies for their donations to independent copay assistance charities. As the list of investigations grows longer, life sciences companies should reassess their policies, procedures and monitoring regarding donations, say attorneys at Paul Hastings LLP.
A recent report by the U.S. Government Accountability Office highlights the important role corporate integrity agreements play in protecting federal health care programs when federal laws are violated. Given their central role in promoting compliance, it is time for the U.S. Department of Health and Human Services’ Office of Inspector General to update its templates and approach, say attorneys with Skadden Arps Slate Meagher & Flom LLP.
While some may say it’s ironic, it’s also embarrassing and enraging that the very industry that offers anti-harassment training, policies and counsel now finds itself the subject of #MeToo headlines. The American Bar Association recommendation that will bring about the greatest change is the call to provide alternative methods for reporting violations, says Beth Schroeder, chair of Raines Feldman LLP's labor and employment group.
A recent Expert Analysis article titled “Challenges In Billing Physician Observation Services” needlessly raises concern among hospitals and physicians about proper billing by physicians for Medicare observation services, says Sheree Kanner of Hogan Lovells.
While the U.S. Department of Health and Human Services Office of Civil Rights has been quiet recently with respect to Health Insurance Portability and Accountability Act enforcement actions, the newly empowered EU data protection authorities will be eager to flex their muscles and show that the General Data Protection Regulation’s extraterritorial reach is not only real, but that noncompliance can be painful, say Nancy Libin and David Saunders of Jenner & Block LLP.
In a profession notoriously averse to change, it should come as no surprise that there is skepticism about the value of having attorneys perform nonbillable tasks. But U.S. law firms have slowly begun to incorporate knowledge lawyers into their operations — and the trend is likely to continue, says Vanessa Pinto Villa of Hogan Lovells.
The Ninth Circuit’s decision last month in Planned Parenthood v. Center for Medical Progress has effectively turned the anti-SLAPP motion into a hybrid of typical motions to dismiss and motions for summary judgment. As a result, defendants have lost the primary benefit of the anti-SLAPP process, says Joseph Gjonola of Roxborough Pomerance Nye & Adreani LLP.